Pharmanutra S.p.A. (BIT:PHN)

Pharmanutra Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	115.5	100.2	82.72	68.11	56.45
Other Revenue	0.65	0.5	0.34	0.03	0.32
Revenue	116.15	100.71	83.06	68.14	56.77
Revenue Growth (YoY)	15.33%	21.24%	21.89%	20.04%	5.78%
Cost of Revenue	56.91	52.09	41.14	35.99	30.25
Gross Profit	59.24	48.62	41.92	32.15	26.52
Selling, General & Admin	26.67	22.55	17.19	12.12	9.95
Other Operating Expenses	1.81	0.43	0.34	0.34	1.11
Operating Expenses	31.88	25.6	18.84	13.86	12.35
Operating Income	27.36	23.02	23.07	18.3	14.17
Interest Expense	-1.06	-0.8	-0.06	-0.02	-0.03
Interest & Investment Income	0.68	0.32	0.13	0.15	0.09
Currency Exchange Gain (Loss)	-0.04	0.08	-0.03	-	0
Other Non Operating Income (Expenses)	0.77	1.17	0.34	0.4	0.66
EBT Excluding Unusual Items	27.71	23.79	23.45	18.83	14.88
Gain (Loss) on Sale of Assets	-0.27	-0.03	-0.03	-0.02	-0.07
Legal Settlements	-0.27	-0.5	-	-	-
Other Unusual Items	-	-	-	-	-1.51
Pretax Income	27.16	23.26	23.42	18.81	13.3
Income Tax Expense	10.61	10.43	8.37	5.04	-0.77
Earnings From Continuing Operations	16.55	12.83	15.05	13.77	14.07
Net Income to Company	16.55	12.83	15.05	13.77	14.07
Minority Interest in Earnings	0.06	-	-	-	-
Net Income	16.61	12.83	15.05	13.77	14.07
Preferred Dividends & Other Adjustments	-	-	-	-	0
Net Income to Common	16.61	12.83	15.05	13.77	14.07
Net Income Growth	29.43%	-14.73%	9.27%	-2.14%	66.45%
Shares Outstanding (Basic)	10	10	10	10	10
Shares Outstanding (Diluted)	10	10	10	10	10
Shares Change (YoY)	-0.61%	-0.05%	-0.09%	-	-
EPS (Basic)	1.73	1.33	1.56	1.42	1.45
EPS (Diluted)	1.73	1.33	1.56	1.42	1.45
EPS Growth	30.22%	-14.69%	9.37%	-2.13%	66.44%
Free Cash Flow	16.25	-1.16	-8.69	15.43	10.12
Free Cash Flow Per Share	1.69	-0.12	-0.90	1.59	1.04
Dividend Per Share	1.000	0.850	0.800	0.710	0.670
Dividend Growth	17.65%	6.25%	12.68%	5.97%	45.65%
Gross Margin	51.00%	48.28%	50.47%	47.18%	46.71%
Operating Margin	23.56%	22.86%	27.78%	26.85%	24.95%
Profit Margin	14.30%	12.74%	18.12%	20.21%	24.79%
Free Cash Flow Margin	13.99%	-1.15%	-10.46%	22.64%	17.82%
EBITDA	30.24	25.44	24.22	19.3	15.1
EBITDA Margin	26.04%	25.26%	29.16%	28.33%	26.60%
D&A For EBITDA	2.88	2.42	1.15	1.01	0.93
EBIT	27.36	23.02	23.07	18.3	14.17
EBIT Margin	23.56%	22.86%	27.78%	26.85%	24.95%
Effective Tax Rate	39.06%	44.83%	35.74%	26.78%	-
Revenue as Reported	116.91	101.96	83.39	68.84	58.68

Updated Jan 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.